Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Relmada Therapeutics is a clinical-stage, publicly traded biotechnology company developing novel medicines that potentially address areas of high unmet medical need in the treatment of central nervous system (CNS) diseases.